Abstract: An apparatus for controlling a lane change in a vehicle is provided. The apparatus includes: a turn signal module to receive an input for a turn signal, a navigation module to obtain map information, a display to output a user interface, and a processor electrically connected with the turn signal lever, the navigation module, and the display. The processor recognizes a diverging section located on a road where the vehicle is traveling, based on the map information obtained by the navigation module when a lane change command is received via the turn signal module, determines whether the vehicle is able to change a driving lane of the vehicle to a diverging lane in the diverging section based on a speed of the vehicle, and controls the vehicle to enter the diverging lane when the vehicle is able to change the driving lane.

Abstract: A lateral acceleration limiting device may include a processor configured to calculate current lateral acceleration of a vehicle, predict forward lateral acceleration, and determine whether the prediction lateral acceleration and the current lateral acceleration are greater than a predetermine reference value, a controller communicatively connected to the processor and configured to determine whether to generate a warning or whether to adjust steering torque, depending on a result determined by the processor, and a steering torque adjusting device communicatively connected to the processor and configured to adjust the steering torque depending on control of the controller.

Abstract: A system for generating a path when a travel lane of a driver's vehicle is changed, may include a detector configured to recognize line information on a front side of the driver's vehicle, an input device configured to input a lane changing command of the driver's vehicle, and a controller configured to generate a lane changing path using vehicle behavior information generated based on the lane changing command and the line information and target behavior information, and to compare a time period until the driver's vehicle overlaps a line when the driver's vehicle changes the line and a time period which is set to maintain a current travel lane to control the lane changing path.

Abstract: An apparatus for automatically setting a speed of a vehicle may include a path guide device configured to obtain information related to a location of the vehicle, a type of a road corresponding to the location, and a speed limit of the road corresponding to the location and a controller configured to be electronically connected to the path guide device, wherein the controller is configured to activate an automatic setting mode for setting a setting speed for autonomous driving of the vehicle to a speed limit of a road corresponding to a current location of the vehicle, when the vehicle enters another type of road from the specified type of road in a state where the automatic setting mode is activated, release the automatic setting mode, and activate the automatic setting mode.

Abstract: A system for generating a path when a travel lane of a driver's vehicle is changed, may include a detector configured to recognize line information on a front side of the driver's vehicle, an input device configured to input a lane changing command of the driver's vehicle, and a controller configured to generate a lane changing path using vehicle behavior information generated based on the lane changing command and the line information and target behavior information, and to compare a time period until the driver's vehicle overlaps a line when the driver's vehicle changes the line and a time period which is set to maintain a current travel lane to control the lane changing path.

Abstract: A driving assist system for a vehicle using navigation information includes: a navigation device providing navigation information; a controller determining whether the vehicle deviates from a navigation route based on a driving lane of the vehicle at or near a junction of a highway, and when the controller determines that the vehicle deviates from the navigation route, performing at least one driving assist operation based on information of a road on which the vehicle is currently driving; and a display device displaying the information of the road on which the vehicle is currently driving.

Abstract: A lane keeping assist method and system may include determining a driving state of a vehicle according to a state of a lane change in which an intention of a driver is reflected after a turn signal is applied, adjusting a criterion for driver override depending on an error between a driving path of the vehicle and a target path according to the driving state of the vehicle, comparing a steering torque of the driver with the adjusted criterion to determine activation or cancellation of the driver override, minimizing the driver's discomfort in the steering operation when the driver intentionally changes the lane.

Abstract: The invention provides siRNA compositions that specifically downregulates expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD).

Abstract: The invention provides siRNA compositions that specifically downregulates expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD).

Abstract: The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure.

Abstract: A carrier free nanoparticle formulation with good circulation stability is made for anticancer drug delivery. Nanocrystals crystalized in the medium containing Pluronic F-127 then coated with albumin (Cim-F-Alb) had the smallest size and the most native albumin, and showed most favorable cell interaction profiles and better stability than commercial albumin based Abraxane formulation, while maintaining comparable cytotoxicity to those of Abraxane and solvent-dissolved paclitaxel (PTX).

Abstract: The invention provides siRNA compositions that specifically downregulates expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD).

Abstract: The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure.

Abstract: The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure.

Abstract: The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure.

Abstract: A complex coacervate delivery system is provided which encapsulates lipophilic nutrients such as, for example, fish oils high in omega-3 fatty acids. The complex coacervate delivery system protects the lipophilic nutrient from degradation, e.g., oxidation and hydrolysis, and also reduces or eliminates the unpleasant taste and odor of the lipophilic nutrient. The complex coacervate delivery system upon ingestion is operative to substantially release the lipophilic nutrient in the lower gastrointestinal tract in a pH-controlled manner. The complex coacervate delivery system may be included in a food or beverage product having a pH value within the range of about 1.5 to about 5.0.

Abstract: The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure.

Abstract: A complex coacervate delivery system is provided which encapsulates lipophilic nutrients such as, for example, fish oils high in omega-3 fatty acids. The complex coacervate delivery system protects the lipophilic nutrient from degradation, e.g., oxidation and hydrolysis, and also reduces or eliminates the unpleasant taste and odor of the lipophilic nutrient. The complex coacervate delivery system upon ingestion is operative to substantially release the lipophilic nutrient in the lower gastrointestinal tract in a pH-controlled manner. The complex coacervate delivery system may be included in a food or beverage product having a pH value within the range of about 1.5 to about 5.0.

Abstract: The present invention generally relates to systems and methods for releasing a compound from an article using an external trigger, for example, magnetic fields. One aspect of the invention is generally directed to an article containing a magnetically-susceptible material. Exposure of the magnetically-susceptible material to a magnetic field, such as an oscillating magnetic field, may cause the magnetically-susceptible material to increase in temperature. This increase in temperature may be used, in some embodiments, to cause the release of a drug or other releasable material from the article. For instance, the drug may be contained in a heat-sensitive material in thermal communication with the magnetically-susceptible material, or the drug may be contained within an enclosure that is isolated, at least in part, by a heat-sensitive material in thermal communication with the magnetically-susceptible material. Other aspects of the invention are directed to systems and methods of making or using such articles, e.

Abstract: A complex coacervate delivery system is provided which encapsulates lipophilic nutrients such as, for example, fish oils high in omega-3 fatty acids. The complex coacervate delivery system protects the lipophilic nutrient from degradation, e.g., oxidation and hydrolysis, and also reduces or eliminates the unpleasant taste and odor of the lipophilic nutrient. The complex coacervate delivery system upon ingestion is operative to substantially release the lipophilic nutrient in the lower gastrointestinal tract in a pH-controlled manner. The complex coacervate delivery system may be included in a food or beverage product having a pH value within the range of about 1.5 to about 5.0.